Clinical Trial Authorisation in China
In China, a Clinical Trial Authorisation (CTA) from Chinese FDA (CFDA) is required for a Clinical Trial of an Investigational Medicinal Product. CTA is needed for Bioequivanlence study (BE) of a genrics in China.
Copyright © 2013-2030 SwiCino Group Ltd · All Rights Reserved